April 2014
Regular 7pm Meeting, April 9th:Discussions about the additional new HCV drugs in the pipeline and the impact to Hepatitis C patients in the US.
Future 2014 meetings:Gilead Sciences, manufacturer of Sovaldi, has agreed to speak at our June 2014 meeting about their FDA approved products, some FDA labelled without peginteferon alpha.
Prospects for other 2014 meetings:
Transplant surgeon, attorneys, psychiatry professional, massage therapy education and treatment experiences, are some of the ideas on the table.
Today's Date:
What States are doing